RISK FACTORS ASSOCIATED WITH HIGH ALTITUDE SICKNESS: A CASE-CONTROL STUDY
Sponsored by B.P. Koirala Institute of Health Sciences
About this trial
Last updated 2 years ago
Study ID
339/2023
Status
Recruiting
Type
Observational
Placebo
No
Accepting
18+ Years
All
Trial Timing
Ended 2 years ago
What is this trial about?
Research Title: RISK FACTORS ASSOCIATED WITH HIGH ALTITUDE SICKNESS: A CASE-CONTROL STUDY
Rationale: The Study will help us to identify risk factors of high altitude sickness among
Nepalese and International patients.
Aims and Objectives:
- To identify risk factors for high altitude sickness, including AMS, HACE, and HAPE.
- To compare the prevalence of high altitude sickness between individuals who ascended
rapidly versus those who ascended slowly.
- To examine the association between high altitude sickness and various demographic and
environmental factors, such as age, sex, altitude, and temperature.
- To evaluate the effectiveness of preventative measures, such as gradual ascent and
medication, in reducing the risk of high altitude sickness Research Hypothesis (if
relevant): N/A
1. Material & Methods:
1. Whether study involves Human/animals or both : Human
2. Population/ participants: Patients presenting in Emergency Ward of District
Hospital, Mustang with AMS (Acute Mountain Sickness), HAPE (High altitude
Pulmonary Oedema) or HACE (High altitude Cerebral Oedema) as CASES Healthy
volunteers who didn't develop any symptoms of AMS/HAPE/HACE after their trip
to high altitude as CONTROLS
3. Type of study design: : Case Control Study
4. Human study :
Inclusion Criteria: Cases: Individuals age 18 years or older who have been
diagnosed with AMS based on a LLS score of ≥3 or HAPE or HACE.
Controls: Individuals age 18 years or older who did not develop AMS during
their trip to high altitude as the cases, and who are matched to cases on age
and sex.
Exclusion Criteria:
- Those who deny consent for participation.
- Age<18 years
- Pregnant Women
5. Expected sample size :
Sample size calculation: Mentioned in methodology
6. Control groups : N/A
7. Probable duration of study: 180 days
8. Setting: Emergency Ward
9. Parameter/Variables to be applied/measured Independent Variables i.
Socio-demographic characteristics such as age, sex, address, nationality.
Dependent Variables:
i. Symptoms of Presentation ii. Ascent Rate iii. Co-morbidities iv. Past History
including previous history of altitude sickness v. Personal History such as
smoking, alcohol intake, recreational drugs vi. Awareness on High Altitude Sickness
vii. Intake of Prophylactic medicine (Acetazolamide) viii. Past history of Covid-19
, TB
Outcome measures:
Primary (main outcome): All dependent variables
(i) Rational for statistical methods to be employed : Data will be entered in
Microsoft Excel and converted it into SPSS for statistical analysis .
Descriptive statistics will be used to summarize the characteristics of cases and
controls. Univariate and multivariate logistic regression analyses will be
performed to assess the association between risk factors and high altitude
sickness. The results will be reported as odds ratios with corresponding 95%
confidence intervals. A p-value of less than 0.05 will be considered statistically
significant.
(ii) Ethical clearance : Ethical clearance will be obtained from National Health
Research Council of Nepal (iii) Permission to use copyright questionnaire/Pro
forma: Not applicable
(j) Maintain the confidentiality of subject Confidentiality of the participants
will be maintained. Whether available resources are adequate: Yes
1. Other resources needed: No
2. For Intervention trial: Not applicable
What are the participation requirements?
Inclusion Criteria
Exclusion Criteria
- Those who deny consent for participation. Age<18 years Pregnant Patient
Locations
Location
Status
Recruiting